These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 35714473)

  • 21. Multi-Target-Directed Ligands as an Effective Strategy for the Treatment of Alzheimer's Disease.
    Kumar B; Thakur A; Dwivedi AR; Kumar R; Kumar V
    Curr Med Chem; 2022; 29(10):1757-1803. PubMed ID: 33982650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel donepezil-chalcone-rivastigmine hybrids as potential multifunctional anti-Alzheimer's agents: Design, synthesis, in vitro biological evaluation, in vivo and in silico studies.
    Sang Z; Bai P; Ban Y; Wang K; Wu A; Mi J; Hu J; Xu R; Zhu G; Wang J; Zhang J; Wang C; Tan Z; Tang L
    Bioorg Chem; 2022 Oct; 127():106007. PubMed ID: 35849893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-target-directed ligands in Alzheimer's disease treatment.
    Bajda M; Guzior N; Ignasik M; Malawska B
    Curr Med Chem; 2011; 18(32):4949-75. PubMed ID: 22050745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of oxidative stress and other pathologies in Alzheimer's disease.
    Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
    Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and pharmacological evaluation of N-benzyl-piperidinyl-aryl-acylhydrazone derivatives as donepezil hybrids: Discovery of novel multi-target anti-alzheimer prototype drug candidates.
    Dias Viegas FP; de Freitas Silva M; Divino da Rocha M; Castelli MR; Riquiel MM; Machado RP; Vaz SM; Simões de Lima LM; Mancini KC; Marques de Oliveira PC; Morais ÉP; Gontijo VS; da Silva FMR; D'Alincourt da Fonseca Peçanha D; Castro NG; Neves GA; Giusti-Paiva A; Vilela FC; Orlandi L; Camps I; Veloso MP; Leomil Coelho LF; Ionta M; Ferreira-Silva GÁ; Pereira RM; Dardenne LE; Guedes IA; de Oliveira Carneiro Junior W; Quaglio Bellozi PM; Pinheiro de Oliveira AC; Ferreira FF; Pruccoli L; Tarozzi A; Viegas C
    Eur J Med Chem; 2018 Mar; 147():48-65. PubMed ID: 29421570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
    Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK
    Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease.
    Mezeiova E; Chalupova K; Nepovimova E; Gorecki L; Prchal L; Malinak D; Kuca K; Soukup O; Korabecny J
    Curr Alzheimer Res; 2019; 16(9):772-800. PubMed ID: 30819078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comprehensive review of multi-target directed ligands in the treatment of Alzheimer's disease.
    Pathak C; Kabra UD
    Bioorg Chem; 2024 Mar; 144():107152. PubMed ID: 38290187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease.
    Purgatorio R; de Candia M; Catto M; Carrieri A; Pisani L; De Palma A; Toma M; Ivanova OA; Voskressensky LG; Altomare CD
    Eur J Med Chem; 2019 Sep; 177():414-424. PubMed ID: 31158754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
    Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N
    Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploration of Potent Multi-target-directed-ligands as Anti-alzheimer's Disease Agents: A Moiety Based Review.
    Teli P; Sahiba N; Soni J; Sethiya A; Agarwal DK; Agarwal S
    Mini Rev Med Chem; 2021; 21(20):3219-3248. PubMed ID: 33663363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR).
    Ferreira JPS; Albuquerque HMT; Cardoso SM; Silva AMS; Silva VLM
    Eur J Med Chem; 2021 Oct; 221():113492. PubMed ID: 33984802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methodologies Related to Computational Models in View of Developing Anti-Alzheimer Drugs: An Overview.
    Baheti K; Kale M
    Curr Drug Discov Technol; 2019; 16(1):66-73. PubMed ID: 29663890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromone-lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities.
    Jalili-Baleh L; Nadri H; Forootanfar H; Küçükkılınç TT; Ayazgök B; Sharifzadeh M; Rahimifard M; Baeeri M; Abdollahi M; Foroumadi A; Khoobi M
    Daru; 2021 Jun; 29(1):23-38. PubMed ID: 33420969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds.
    Jalili-Baleh L; Forootanfar H; Küçükkılınç TT; Nadri H; Abdolahi Z; Ameri A; Jafari M; Ayazgok B; Baeeri M; Rahimifard M; Abbas Bukhari SN; Abdollahi M; Ganjali MR; Emami S; Khoobi M; Foroumadi A
    Eur J Med Chem; 2018 May; 152():600-614. PubMed ID: 29763808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease.
    Jalili-Baleh L; Babaei E; Abdpour S; Nasir Abbas Bukhari S; Foroumadi A; Ramazani A; Sharifzadeh M; Abdollahi M; Khoobi M
    Eur J Med Chem; 2018 May; 152():570-589. PubMed ID: 29763806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent Advances in Multi-target Anti-Alzheimer Disease Compounds (2013 Up to the Present).
    Wang N; Qiu P; Cui W; Yan X; Zhang B; He S
    Curr Med Chem; 2019; 26(30):5684-5710. PubMed ID: 30501591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with β-amyloid anti-aggregation properties and beneficial effects on memory in vivo.
    Więckowska A; Więckowski K; Bajda M; Brus B; Sałat K; Czerwińska P; Gobec S; Filipek B; Malawska B
    Bioorg Med Chem; 2015 May; 23(10):2445-57. PubMed ID: 25868744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From Hybrids to New Scaffolds: The Latest Medicinal Chemistry Goals in Multi-target Directed Ligands for Alzheimer's Disease.
    Alarcón-Espósito J; Mallea M; Rodríguez-Lavado J
    Curr Neuropharmacol; 2021; 19(6):832-867. PubMed ID: 32928087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent Advancements in the Treatment of Alzheimer's Disease: A Multitarget-directed Ligand Approach.
    Kumar S; Mahajan A; Ambatwar R; Khatik GL
    Curr Med Chem; 2024; 31(37):6032-6062. PubMed ID: 37861025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.